FDA may fine Merck over Diabetes drug

U.S. drug regulators may fine Merck for failing to test whether its diabetes drugs Januvia and Janumet can raise the risk of an inflamed pancreas, according to a warning letter posted online on Tuesday.

Read more

Posted in Drugs